Los Angeles Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,219
| Closed | -$276K | – | 1143 |
|
|
2024
Q3 | $276K | Sell |
5,219
-9,408
| -64% | -$497K | ﹤0.01% | 1037 |
|
|
2024
Q2 | $792K | Sell |
14,627
-3,190
| -18% | -$173K | ﹤0.01% | 731 |
|
|
2024
Q1 | $1.25M | Buy |
+17,817
| New | +$1.25M | ﹤0.01% | 619 |
|
|
2018
Q3 | – | Sell |
-11,059
| Closed | -$92K | – | 1409 |
|
|
2018
Q2 | $92K | Hold |
11,059
| – | – | ﹤0.01% | 1418 |
|
|
2018
Q1 | $80K | Sell |
11,059
-15,689
| -59% | -$113K | ﹤0.01% | 1301 |
|
|
2017
Q4 | $218K | Sell |
26,748
-28,339
| -51% | -$231K | ﹤0.01% | 1251 |
|
|
2017
Q3 | $799K | Buy |
+55,087
| New | +$799K | ﹤0.01% | 890 |
|
|
2016
Q1 | – | Sell |
-12,470
| Closed | -$130K | – | 1146 |
|
|
2015
Q4 | $130K | Buy |
+12,470
| New | +$130K | ﹤0.01% | 1097 |
|